Richard Vosser

Stock Analyst at JP Morgan

(2.34)

# 1,428

Out of 4,667 analysts

10

Total ratings

60%

Success rate

5.32%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General Biotechnology

Stocks Rated by Richard Vosser

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MOLN Molecular Partners AG	Maintains: Neutral	$6.6 → $4.5	$5.34	-15.73%	1	Dec 5, 2023
	NVO Novo Nordisk	Upgrades: Overweight	n/a	$102.20	-	7	Jun 7, 2022
	SNY Sanofi	Upgrades: Overweight	n/a	$47.66	-	2	Jan 6, 2020

Molecular Partners AG

Dec 5, 2023

Maintains: Neutral

Price Target: $6.6 → $4.5

Current: $5.34

Upside: -15.73%

Novo Nordisk

Jun 7, 2022

Upgrades: Overweight

Price Target: n/a

Current: $102.20

Upside: -

Sanofi

Jan 6, 2020

Upgrades: Overweight

Price Target: n/a

Current: $47.66

Upside: -